4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The survival rate for men with International Society of Urological Pathology (ISUP) grade 2 prostate cancer (PCa) without invasive cribriform (CR) and intraductal carcinoma (IDC) is similar to that for ISUP grade 1. If updated into the European Randomized Study of Screening for Prostate Cancer (ERSPC Rotterdam) risk calculator number 3 (RC3), this may further improve upfront selection of men who need a biopsy.

          Related collections

          Author and article information

          Journal
          Eur. Urol.
          European urology
          Elsevier BV
          1873-7560
          0302-2838
          Jul 2017
          : 72
          : 1
          Affiliations
          [1 ] Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: m.roobol@erasmusmc.nl.
          [2 ] Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
          [3 ] Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
          Article
          S0302-2838(17)30058-1
          10.1016/j.eururo.2017.01.033
          28162815
          d7103152-a7d7-401b-ba25-c0a809d56e54
          History

          Prognosis,Risk calculator,Cribriform,International Society of Urological Pathology grading system,Intraductal carcinoma,Prediction model,Prostate cancer

          Comments

          Comment on this article